España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Junior Analyst
JPM Studies Crop Ecomonics In Regard to DE; Ups Earnings And Maintains Price Target Of $72.00
Goldman Meets With Target (TGT) Management; Gives $59.00 Price Target; Maintains Neutral
Adtran (ADTN) Reported Solid FQ2 Top and Bottom Line Beat, Goldman Ups Price Target To $32.00, Maintains Neutral Rating
IGTE Has Great Quarter; Jeffries and Co., Ups Target To $19.00
Forest Labs (FRX) To Report Earnings On Tuesday, July 20th, Jeffries and Co., Looks For Solid Numbers and Possible Raised Guidance, Maintains $34.00 Price Target
Sonic Wall (SNWL) Still Rated Overweight At JPM Despite Takeover Cap Price. Is A Higher Bid Coming?
DIVX Still Trading Under Acquisition Target Price, Is There Upside Despite JPMorgan's Downgrade and Possible Shareholder Lawsuits?
JPM Morgan Reviews and Renews Overweight Ratings On MCD And Yum In Spite Of FX Moves
Celgene (CELG) Upgraded From Hold To Buy At Jeffries & Co. With a $63.00 Price Target
JP Morgan Reiterates Buy On Pactiv Corp (PTV); Raises Price Target To $34.00,"Floor" Is Given Due To Takeover Talk
JP Morgan Rates Dreamworks (DWA) Neutral With A $32.00 Price Target As Shrek Forever After Results Are Awaited, Relief Rally For DWA?
JP Morgan Adjusts EPS On Ship Financial International (SFL) Maintains $22.00 Price Target
JP Morgan Resumes Coverage of Garmin (GRMN) With An Underweight With A Target of $30.50
Deutsch Bank Maintains Hold On Sigma Designs (SIGM) With A $14.00 Price Target
Citi Maintains Buy On Deere (DE), Ups Price Target To $70.00 Notes Higher EPS And Dividend Hike
Oppenheimer Maintains Attractive Outlook And Price Target On China Biotech Company 3SBIO (SSRX), A Possible Takeout Target?
Oppenheimer States Underperform on Cadence (CADX) Noting New Product Delay And Cash Pressures
Hansen Transmissions Rated Overweight at Piper Jaffray; Tie-up With Large Chinese Partner Revealed
Anadarko Petroleum (APC) Should Benefit Long Term From Cleanup And "Un-Booked" Potential, JP Morgan Maintains Overweight
WuXi PharmaTech Inc. (Wx) Upside Exists Despite Pending Merger According To Oppenheimer